Intrinsiqs

Is Fennec Pharmaceuticals Inc. overvalued?

Fennec Pharmaceuticals Inc. (FENC) — key valuation metrics and fundamentals.

No verdict
Price
$10.95
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$380.4M
Dividend yield
0.0%
Return on equity
-11.7%
Sector
Healthcare

See the full interactive analysis →

Fair value compares FENC's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.